Can amyloid PET differentiate “pure” LBD from AD with or without LBD copathology?
Authors:
- 21 January 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Neurology
- Vol. 94 (3) , 103-104
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- β-Amyloid PET and neuropathology in dementia with Lewy bodiesNeurology, 2020
- Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body diseaseNeurology, 2019
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associatedBrain, 2018
- Considering sex and gender in Alzheimer disease and other dementiasDialogues in clinical neuroscience, 2016
- Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changesNeurobiology of Aging, 2015
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's diseaseBrain, 2008
- Cerebral amyloid angiopathy in Lewy body diseaseJournal of Neural Transmission, 2008
- Amyloid, hypometabolism, and cognition in Alzheimer diseaseNeurology, 2007
- Mixed DementiaJAMA, 2004
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)Neurology, 1996